Literature DB >> 9177605

Circadian rhythm of serum erythropoietin in healthy subjects.

P Pasqualetti1, R Casale.   

Abstract

BACKGROUND: The diurnal rhythm in the circulating serum levels of erythropoietin (EPO) was investigated in healthy subjects.
METHODS: Venous blood samples were drawn during the span of a whole day every four hours, starting from midnight, for the determination of serum Epo levels by RIA in 40 clinically healthy normocytemic subjects, 27 males and 13 females, aged 30-75 years. Statistical analysis was carried out by means of the "cosinor" method.
RESULTS: Serum EPO presents a significant (p < 0.05) circadian rhythm with higher levels in the afternoon and lower levels in the nightime.
CONCLUSIONS: These data confirm the presence of a circadian rhythm in serum EPO levels. The mechanisms behind the circadian rhythmicity are still unknown. For clinical evaluation of the serum EPO values, the time of day for collection of blood samples has to be taken into consideration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9177605

Source DB:  PubMed          Journal:  Riv Eur Sci Med Farmacol        ISSN: 0392-291X


  9 in total

1.  A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection.

Authors:  Akashi Togawa; Takanori Tanaka; Satoru Nagashima; Hiroyuki Keta; Yasue Kobayashi; Yasuhiro Nishikawa; Masanobu Yanai; Hideji Tanaka
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

2.  Serum erythropoietin level and mortality in kidney transplant recipients.

Authors:  Miklos Z Molnar; Adam G Tabak; Ahsan Alam; Maria E Czira; Anna Rudas; Akos Ujszaszi; Gabriella Beko; Marta Novak; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

3.  First-in-man-proof of concept study with molidustat: a novel selective oral HIF-prolyl hydroxylase inhibitor for the treatment of renal anaemia.

Authors:  M Böttcher; S Lentini; E R Arens; A Kaiser; D van der Mey; U Thuss; D Kubitza; G Wensing
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

Review 4.  Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?

Authors:  Farhanah Yousaf; Bruce Spinowitz
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

5.  Regulation of clock-controlled genes in mammals.

Authors:  Katarzyna Bozek; Angela Relógio; Szymon M Kielbasa; Markus Heine; Christof Dame; Achim Kramer; Hanspeter Herzel
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

6.  Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers.

Authors:  Wojciech Krzyzanski; Elzbieta Wyska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-11       Impact factor: 3.000

7.  The Cinderella syndrome: why do malaria-infected cells burst at midnight?

Authors:  Nicole Mideo; Sarah E Reece; Adrian L Smith; C Jessica E Metcalf
Journal:  Trends Parasitol       Date:  2012-12-17

8.  Hemoglobin and Erythropoietin After Commercial Saturation Diving.

Authors:  Fatima Z Kiboub; Costantino Balestra; Øyvind Loennechen; Ingrid Eftedal
Journal:  Front Physiol       Date:  2018-08-21       Impact factor: 4.566

9.  Integrated RNA-seq Analysis Indicates Asynchrony in Clock Genes between Tissues under Spaceflight.

Authors:  Shin-Ichiro Fujita; Lindsay Rutter; Quang Ong; Masafumi Muratani
Journal:  Life (Basel)       Date:  2020-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.